Medical Care
Global Drug Phenotypic Screening Platform Market Research Report 2025
- May 12, 25
- ID: 235922
- Pages: 83
- Figures: 85
- Views: 36
The global market for Drug Phenotypic Screening Platform was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Drug Phenotypic Screening Platform is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Drug Phenotypic Screening Platform is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Drug Phenotypic Screening Platform in Pharmaceutical Company is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Drug Phenotypic Screening Platform include Melior Discovery, Creative Biolabs, PerkinElmer, TargetMol, MIMETAS, Evotec, ThermoScientific, Eurofins Discovery, Horizon Discovery, Crown Bioscience, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Drug Phenotypic Screening Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Phenotypic Screening Platform.
The Drug Phenotypic Screening Platform market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Phenotypic Screening Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Phenotypic Screening Platform companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Melior Discovery
Creative Biolabs
PerkinElmer
TargetMol
MIMETAS
Evotec
ThermoScientific
Eurofins Discovery
Horizon Discovery
Crown Bioscience
Pharmaron
HD Biosciences
Segment by Type
In Vivo Screening
In Vitro Screening
Segment by Application
Pharmaceutical Company
Research Institute
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Phenotypic Screening Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Drug Phenotypic Screening Platform is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Drug Phenotypic Screening Platform is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Drug Phenotypic Screening Platform in Pharmaceutical Company is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Drug Phenotypic Screening Platform include Melior Discovery, Creative Biolabs, PerkinElmer, TargetMol, MIMETAS, Evotec, ThermoScientific, Eurofins Discovery, Horizon Discovery, Crown Bioscience, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Drug Phenotypic Screening Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Phenotypic Screening Platform.
The Drug Phenotypic Screening Platform market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Phenotypic Screening Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Phenotypic Screening Platform companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Melior Discovery
Creative Biolabs
PerkinElmer
TargetMol
MIMETAS
Evotec
ThermoScientific
Eurofins Discovery
Horizon Discovery
Crown Bioscience
Pharmaron
HD Biosciences
Segment by Type
In Vivo Screening
In Vitro Screening
Segment by Application
Pharmaceutical Company
Research Institute
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Phenotypic Screening Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Phenotypic Screening Platform Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 In Vivo Screening
1.2.3 In Vitro Screening
1.3 Market by Application
1.3.1 Global Drug Phenotypic Screening Platform Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Company
1.3.3 Research Institute
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Phenotypic Screening Platform Market Perspective (2020-2031)
2.2 Global Drug Phenotypic Screening Platform Growth Trends by Region
2.2.1 Global Drug Phenotypic Screening Platform Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drug Phenotypic Screening Platform Historic Market Size by Region (2020-2025)
2.2.3 Drug Phenotypic Screening Platform Forecasted Market Size by Region (2026-2031)
2.3 Drug Phenotypic Screening Platform Market Dynamics
2.3.1 Drug Phenotypic Screening Platform Industry Trends
2.3.2 Drug Phenotypic Screening Platform Market Drivers
2.3.3 Drug Phenotypic Screening Platform Market Challenges
2.3.4 Drug Phenotypic Screening Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Phenotypic Screening Platform Players by Revenue
3.1.1 Global Top Drug Phenotypic Screening Platform Players by Revenue (2020-2025)
3.1.2 Global Drug Phenotypic Screening Platform Revenue Market Share by Players (2020-2025)
3.2 Global Drug Phenotypic Screening Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug Phenotypic Screening Platform Revenue
3.4 Global Drug Phenotypic Screening Platform Market Concentration Ratio
3.4.1 Global Drug Phenotypic Screening Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Phenotypic Screening Platform Revenue in 2024
3.5 Global Key Players of Drug Phenotypic Screening Platform Head office and Area Served
3.6 Global Key Players of Drug Phenotypic Screening Platform, Product and Application
3.7 Global Key Players of Drug Phenotypic Screening Platform, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Phenotypic Screening Platform Breakdown Data by Type
4.1 Global Drug Phenotypic Screening Platform Historic Market Size by Type (2020-2025)
4.2 Global Drug Phenotypic Screening Platform Forecasted Market Size by Type (2026-2031)
5 Drug Phenotypic Screening Platform Breakdown Data by Application
5.1 Global Drug Phenotypic Screening Platform Historic Market Size by Application (2020-2025)
5.2 Global Drug Phenotypic Screening Platform Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drug Phenotypic Screening Platform Market Size (2020-2031)
6.2 North America Drug Phenotypic Screening Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drug Phenotypic Screening Platform Market Size by Country (2020-2025)
6.4 North America Drug Phenotypic Screening Platform Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Phenotypic Screening Platform Market Size (2020-2031)
7.2 Europe Drug Phenotypic Screening Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drug Phenotypic Screening Platform Market Size by Country (2020-2025)
7.4 Europe Drug Phenotypic Screening Platform Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Phenotypic Screening Platform Market Size (2020-2031)
8.2 Asia-Pacific Drug Phenotypic Screening Platform Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drug Phenotypic Screening Platform Market Size by Region (2020-2025)
8.4 Asia-Pacific Drug Phenotypic Screening Platform Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Phenotypic Screening Platform Market Size (2020-2031)
9.2 Latin America Drug Phenotypic Screening Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drug Phenotypic Screening Platform Market Size by Country (2020-2025)
9.4 Latin America Drug Phenotypic Screening Platform Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Phenotypic Screening Platform Market Size (2020-2031)
10.2 Middle East & Africa Drug Phenotypic Screening Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drug Phenotypic Screening Platform Market Size by Country (2020-2025)
10.4 Middle East & Africa Drug Phenotypic Screening Platform Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Melior Discovery
11.1.1 Melior Discovery Company Details
11.1.2 Melior Discovery Business Overview
11.1.3 Melior Discovery Drug Phenotypic Screening Platform Introduction
11.1.4 Melior Discovery Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.1.5 Melior Discovery Recent Development
11.2 Creative Biolabs
11.2.1 Creative Biolabs Company Details
11.2.2 Creative Biolabs Business Overview
11.2.3 Creative Biolabs Drug Phenotypic Screening Platform Introduction
11.2.4 Creative Biolabs Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.2.5 Creative Biolabs Recent Development
11.3 PerkinElmer
11.3.1 PerkinElmer Company Details
11.3.2 PerkinElmer Business Overview
11.3.3 PerkinElmer Drug Phenotypic Screening Platform Introduction
11.3.4 PerkinElmer Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.3.5 PerkinElmer Recent Development
11.4 TargetMol
11.4.1 TargetMol Company Details
11.4.2 TargetMol Business Overview
11.4.3 TargetMol Drug Phenotypic Screening Platform Introduction
11.4.4 TargetMol Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.4.5 TargetMol Recent Development
11.5 MIMETAS
11.5.1 MIMETAS Company Details
11.5.2 MIMETAS Business Overview
11.5.3 MIMETAS Drug Phenotypic Screening Platform Introduction
11.5.4 MIMETAS Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.5.5 MIMETAS Recent Development
11.6 Evotec
11.6.1 Evotec Company Details
11.6.2 Evotec Business Overview
11.6.3 Evotec Drug Phenotypic Screening Platform Introduction
11.6.4 Evotec Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.6.5 Evotec Recent Development
11.7 ThermoScientific
11.7.1 ThermoScientific Company Details
11.7.2 ThermoScientific Business Overview
11.7.3 ThermoScientific Drug Phenotypic Screening Platform Introduction
11.7.4 ThermoScientific Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.7.5 ThermoScientific Recent Development
11.8 Eurofins Discovery
11.8.1 Eurofins Discovery Company Details
11.8.2 Eurofins Discovery Business Overview
11.8.3 Eurofins Discovery Drug Phenotypic Screening Platform Introduction
11.8.4 Eurofins Discovery Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.8.5 Eurofins Discovery Recent Development
11.9 Horizon Discovery
11.9.1 Horizon Discovery Company Details
11.9.2 Horizon Discovery Business Overview
11.9.3 Horizon Discovery Drug Phenotypic Screening Platform Introduction
11.9.4 Horizon Discovery Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.9.5 Horizon Discovery Recent Development
11.10 Crown Bioscience
11.10.1 Crown Bioscience Company Details
11.10.2 Crown Bioscience Business Overview
11.10.3 Crown Bioscience Drug Phenotypic Screening Platform Introduction
11.10.4 Crown Bioscience Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.10.5 Crown Bioscience Recent Development
11.11 Pharmaron
11.11.1 Pharmaron Company Details
11.11.2 Pharmaron Business Overview
11.11.3 Pharmaron Drug Phenotypic Screening Platform Introduction
11.11.4 Pharmaron Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.11.5 Pharmaron Recent Development
11.12 HD Biosciences
11.12.1 HD Biosciences Company Details
11.12.2 HD Biosciences Business Overview
11.12.3 HD Biosciences Drug Phenotypic Screening Platform Introduction
11.12.4 HD Biosciences Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.12.5 HD Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Phenotypic Screening Platform Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 In Vivo Screening
1.2.3 In Vitro Screening
1.3 Market by Application
1.3.1 Global Drug Phenotypic Screening Platform Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Company
1.3.3 Research Institute
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Phenotypic Screening Platform Market Perspective (2020-2031)
2.2 Global Drug Phenotypic Screening Platform Growth Trends by Region
2.2.1 Global Drug Phenotypic Screening Platform Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drug Phenotypic Screening Platform Historic Market Size by Region (2020-2025)
2.2.3 Drug Phenotypic Screening Platform Forecasted Market Size by Region (2026-2031)
2.3 Drug Phenotypic Screening Platform Market Dynamics
2.3.1 Drug Phenotypic Screening Platform Industry Trends
2.3.2 Drug Phenotypic Screening Platform Market Drivers
2.3.3 Drug Phenotypic Screening Platform Market Challenges
2.3.4 Drug Phenotypic Screening Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Phenotypic Screening Platform Players by Revenue
3.1.1 Global Top Drug Phenotypic Screening Platform Players by Revenue (2020-2025)
3.1.2 Global Drug Phenotypic Screening Platform Revenue Market Share by Players (2020-2025)
3.2 Global Drug Phenotypic Screening Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug Phenotypic Screening Platform Revenue
3.4 Global Drug Phenotypic Screening Platform Market Concentration Ratio
3.4.1 Global Drug Phenotypic Screening Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Phenotypic Screening Platform Revenue in 2024
3.5 Global Key Players of Drug Phenotypic Screening Platform Head office and Area Served
3.6 Global Key Players of Drug Phenotypic Screening Platform, Product and Application
3.7 Global Key Players of Drug Phenotypic Screening Platform, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Phenotypic Screening Platform Breakdown Data by Type
4.1 Global Drug Phenotypic Screening Platform Historic Market Size by Type (2020-2025)
4.2 Global Drug Phenotypic Screening Platform Forecasted Market Size by Type (2026-2031)
5 Drug Phenotypic Screening Platform Breakdown Data by Application
5.1 Global Drug Phenotypic Screening Platform Historic Market Size by Application (2020-2025)
5.2 Global Drug Phenotypic Screening Platform Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drug Phenotypic Screening Platform Market Size (2020-2031)
6.2 North America Drug Phenotypic Screening Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drug Phenotypic Screening Platform Market Size by Country (2020-2025)
6.4 North America Drug Phenotypic Screening Platform Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Phenotypic Screening Platform Market Size (2020-2031)
7.2 Europe Drug Phenotypic Screening Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drug Phenotypic Screening Platform Market Size by Country (2020-2025)
7.4 Europe Drug Phenotypic Screening Platform Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Phenotypic Screening Platform Market Size (2020-2031)
8.2 Asia-Pacific Drug Phenotypic Screening Platform Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drug Phenotypic Screening Platform Market Size by Region (2020-2025)
8.4 Asia-Pacific Drug Phenotypic Screening Platform Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Phenotypic Screening Platform Market Size (2020-2031)
9.2 Latin America Drug Phenotypic Screening Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drug Phenotypic Screening Platform Market Size by Country (2020-2025)
9.4 Latin America Drug Phenotypic Screening Platform Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Phenotypic Screening Platform Market Size (2020-2031)
10.2 Middle East & Africa Drug Phenotypic Screening Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drug Phenotypic Screening Platform Market Size by Country (2020-2025)
10.4 Middle East & Africa Drug Phenotypic Screening Platform Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Melior Discovery
11.1.1 Melior Discovery Company Details
11.1.2 Melior Discovery Business Overview
11.1.3 Melior Discovery Drug Phenotypic Screening Platform Introduction
11.1.4 Melior Discovery Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.1.5 Melior Discovery Recent Development
11.2 Creative Biolabs
11.2.1 Creative Biolabs Company Details
11.2.2 Creative Biolabs Business Overview
11.2.3 Creative Biolabs Drug Phenotypic Screening Platform Introduction
11.2.4 Creative Biolabs Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.2.5 Creative Biolabs Recent Development
11.3 PerkinElmer
11.3.1 PerkinElmer Company Details
11.3.2 PerkinElmer Business Overview
11.3.3 PerkinElmer Drug Phenotypic Screening Platform Introduction
11.3.4 PerkinElmer Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.3.5 PerkinElmer Recent Development
11.4 TargetMol
11.4.1 TargetMol Company Details
11.4.2 TargetMol Business Overview
11.4.3 TargetMol Drug Phenotypic Screening Platform Introduction
11.4.4 TargetMol Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.4.5 TargetMol Recent Development
11.5 MIMETAS
11.5.1 MIMETAS Company Details
11.5.2 MIMETAS Business Overview
11.5.3 MIMETAS Drug Phenotypic Screening Platform Introduction
11.5.4 MIMETAS Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.5.5 MIMETAS Recent Development
11.6 Evotec
11.6.1 Evotec Company Details
11.6.2 Evotec Business Overview
11.6.3 Evotec Drug Phenotypic Screening Platform Introduction
11.6.4 Evotec Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.6.5 Evotec Recent Development
11.7 ThermoScientific
11.7.1 ThermoScientific Company Details
11.7.2 ThermoScientific Business Overview
11.7.3 ThermoScientific Drug Phenotypic Screening Platform Introduction
11.7.4 ThermoScientific Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.7.5 ThermoScientific Recent Development
11.8 Eurofins Discovery
11.8.1 Eurofins Discovery Company Details
11.8.2 Eurofins Discovery Business Overview
11.8.3 Eurofins Discovery Drug Phenotypic Screening Platform Introduction
11.8.4 Eurofins Discovery Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.8.5 Eurofins Discovery Recent Development
11.9 Horizon Discovery
11.9.1 Horizon Discovery Company Details
11.9.2 Horizon Discovery Business Overview
11.9.3 Horizon Discovery Drug Phenotypic Screening Platform Introduction
11.9.4 Horizon Discovery Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.9.5 Horizon Discovery Recent Development
11.10 Crown Bioscience
11.10.1 Crown Bioscience Company Details
11.10.2 Crown Bioscience Business Overview
11.10.3 Crown Bioscience Drug Phenotypic Screening Platform Introduction
11.10.4 Crown Bioscience Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.10.5 Crown Bioscience Recent Development
11.11 Pharmaron
11.11.1 Pharmaron Company Details
11.11.2 Pharmaron Business Overview
11.11.3 Pharmaron Drug Phenotypic Screening Platform Introduction
11.11.4 Pharmaron Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.11.5 Pharmaron Recent Development
11.12 HD Biosciences
11.12.1 HD Biosciences Company Details
11.12.2 HD Biosciences Business Overview
11.12.3 HD Biosciences Drug Phenotypic Screening Platform Introduction
11.12.4 HD Biosciences Revenue in Drug Phenotypic Screening Platform Business (2020-2025)
11.12.5 HD Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Drug Phenotypic Screening Platform Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of In Vivo Screening
Table 3. Key Players of In Vitro Screening
Table 4. Global Drug Phenotypic Screening Platform Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Drug Phenotypic Screening Platform Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Drug Phenotypic Screening Platform Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Drug Phenotypic Screening Platform Market Share by Region (2020-2025)
Table 8. Global Drug Phenotypic Screening Platform Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Drug Phenotypic Screening Platform Market Share by Region (2026-2031)
Table 10. Drug Phenotypic Screening Platform Market Trends
Table 11. Drug Phenotypic Screening Platform Market Drivers
Table 12. Drug Phenotypic Screening Platform Market Challenges
Table 13. Drug Phenotypic Screening Platform Market Restraints
Table 14. Global Drug Phenotypic Screening Platform Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Drug Phenotypic Screening Platform Market Share by Players (2020-2025)
Table 16. Global Top Drug Phenotypic Screening Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Phenotypic Screening Platform as of 2024)
Table 17. Ranking of Global Top Drug Phenotypic Screening Platform Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Drug Phenotypic Screening Platform Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Drug Phenotypic Screening Platform, Headquarters and Area Served
Table 20. Global Key Players of Drug Phenotypic Screening Platform, Product and Application
Table 21. Global Key Players of Drug Phenotypic Screening Platform, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug Phenotypic Screening Platform Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Drug Phenotypic Screening Platform Revenue Market Share by Type (2020-2025)
Table 25. Global Drug Phenotypic Screening Platform Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Drug Phenotypic Screening Platform Revenue Market Share by Type (2026-2031)
Table 27. Global Drug Phenotypic Screening Platform Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Drug Phenotypic Screening Platform Revenue Market Share by Application (2020-2025)
Table 29. Global Drug Phenotypic Screening Platform Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Drug Phenotypic Screening Platform Revenue Market Share by Application (2026-2031)
Table 31. North America Drug Phenotypic Screening Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Drug Phenotypic Screening Platform Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Drug Phenotypic Screening Platform Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Drug Phenotypic Screening Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Drug Phenotypic Screening Platform Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Drug Phenotypic Screening Platform Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Drug Phenotypic Screening Platform Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Drug Phenotypic Screening Platform Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Drug Phenotypic Screening Platform Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Drug Phenotypic Screening Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Drug Phenotypic Screening Platform Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Drug Phenotypic Screening Platform Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Drug Phenotypic Screening Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Drug Phenotypic Screening Platform Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Drug Phenotypic Screening Platform Market Size by Country (2026-2031) & (US$ Million)
Table 46. Melior Discovery Company Details
Table 47. Melior Discovery Business Overview
Table 48. Melior Discovery Drug Phenotypic Screening Platform Product
Table 49. Melior Discovery Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)
Table 50. Melior Discovery Recent Development
Table 51. Creative Biolabs Company Details
Table 52. Creative Biolabs Business Overview
Table 53. Creative Biolabs Drug Phenotypic Screening Platform Product
Table 54. Creative Biolabs Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)
Table 55. Creative Biolabs Recent Development
Table 56. PerkinElmer Company Details
Table 57. PerkinElmer Business Overview
Table 58. PerkinElmer Drug Phenotypic Screening Platform Product
Table 59. PerkinElmer Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)
Table 60. PerkinElmer Recent Development
Table 61. TargetMol Company Details
Table 62. TargetMol Business Overview
Table 63. TargetMol Drug Phenotypic Screening Platform Product
Table 64. TargetMol Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)
Table 65. TargetMol Recent Development
Table 66. MIMETAS Company Details
Table 67. MIMETAS Business Overview
Table 68. MIMETAS Drug Phenotypic Screening Platform Product
Table 69. MIMETAS Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)
Table 70. MIMETAS Recent Development
Table 71. Evotec Company Details
Table 72. Evotec Business Overview
Table 73. Evotec Drug Phenotypic Screening Platform Product
Table 74. Evotec Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)
Table 75. Evotec Recent Development
Table 76. ThermoScientific Company Details
Table 77. ThermoScientific Business Overview
Table 78. ThermoScientific Drug Phenotypic Screening Platform Product
Table 79. ThermoScientific Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)
Table 80. ThermoScientific Recent Development
Table 81. Eurofins Discovery Company Details
Table 82. Eurofins Discovery Business Overview
Table 83. Eurofins Discovery Drug Phenotypic Screening Platform Product
Table 84. Eurofins Discovery Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)
Table 85. Eurofins Discovery Recent Development
Table 86. Horizon Discovery Company Details
Table 87. Horizon Discovery Business Overview
Table 88. Horizon Discovery Drug Phenotypic Screening Platform Product
Table 89. Horizon Discovery Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)
Table 90. Horizon Discovery Recent Development
Table 91. Crown Bioscience Company Details
Table 92. Crown Bioscience Business Overview
Table 93. Crown Bioscience Drug Phenotypic Screening Platform Product
Table 94. Crown Bioscience Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)
Table 95. Crown Bioscience Recent Development
Table 96. Pharmaron Company Details
Table 97. Pharmaron Business Overview
Table 98. Pharmaron Drug Phenotypic Screening Platform Product
Table 99. Pharmaron Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)
Table 100. Pharmaron Recent Development
Table 101. HD Biosciences Company Details
Table 102. HD Biosciences Business Overview
Table 103. HD Biosciences Drug Phenotypic Screening Platform Product
Table 104. HD Biosciences Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)
Table 105. HD Biosciences Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Drug Phenotypic Screening Platform Picture
Figure 2. Global Drug Phenotypic Screening Platform Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drug Phenotypic Screening Platform Market Share by Type: 2024 VS 2031
Figure 4. In Vivo Screening Features
Figure 5. In Vitro Screening Features
Figure 6. Global Drug Phenotypic Screening Platform Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Drug Phenotypic Screening Platform Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical Company Case Studies
Figure 9. Research Institute Case Studies
Figure 10. Others Case Studies
Figure 11. Drug Phenotypic Screening Platform Report Years Considered
Figure 12. Global Drug Phenotypic Screening Platform Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Drug Phenotypic Screening Platform Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Drug Phenotypic Screening Platform Market Share by Region: 2024 VS 2031
Figure 15. Global Drug Phenotypic Screening Platform Market Share by Players in 2024
Figure 16. Global Top Drug Phenotypic Screening Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Phenotypic Screening Platform as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Drug Phenotypic Screening Platform Revenue in 2024
Figure 18. North America Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Drug Phenotypic Screening Platform Market Share by Country (2020-2031)
Figure 20. United States Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Drug Phenotypic Screening Platform Market Share by Country (2020-2031)
Figure 24. Germany Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Drug Phenotypic Screening Platform Market Share by Region (2020-2031)
Figure 32. China Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Drug Phenotypic Screening Platform Market Share by Country (2020-2031)
Figure 40. Mexico Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Drug Phenotypic Screening Platform Market Share by Country (2020-2031)
Figure 44. Turkey Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Melior Discovery Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)
Figure 48. Creative Biolabs Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)
Figure 49. PerkinElmer Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)
Figure 50. TargetMol Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)
Figure 51. MIMETAS Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)
Figure 52. Evotec Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)
Figure 53. ThermoScientific Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)
Figure 54. Eurofins Discovery Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)
Figure 55. Horizon Discovery Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)
Figure 56. Crown Bioscience Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)
Figure 57. Pharmaron Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)
Figure 58. HD Biosciences Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Drug Phenotypic Screening Platform Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of In Vivo Screening
Table 3. Key Players of In Vitro Screening
Table 4. Global Drug Phenotypic Screening Platform Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Drug Phenotypic Screening Platform Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Drug Phenotypic Screening Platform Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Drug Phenotypic Screening Platform Market Share by Region (2020-2025)
Table 8. Global Drug Phenotypic Screening Platform Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Drug Phenotypic Screening Platform Market Share by Region (2026-2031)
Table 10. Drug Phenotypic Screening Platform Market Trends
Table 11. Drug Phenotypic Screening Platform Market Drivers
Table 12. Drug Phenotypic Screening Platform Market Challenges
Table 13. Drug Phenotypic Screening Platform Market Restraints
Table 14. Global Drug Phenotypic Screening Platform Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Drug Phenotypic Screening Platform Market Share by Players (2020-2025)
Table 16. Global Top Drug Phenotypic Screening Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Phenotypic Screening Platform as of 2024)
Table 17. Ranking of Global Top Drug Phenotypic Screening Platform Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Drug Phenotypic Screening Platform Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Drug Phenotypic Screening Platform, Headquarters and Area Served
Table 20. Global Key Players of Drug Phenotypic Screening Platform, Product and Application
Table 21. Global Key Players of Drug Phenotypic Screening Platform, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug Phenotypic Screening Platform Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Drug Phenotypic Screening Platform Revenue Market Share by Type (2020-2025)
Table 25. Global Drug Phenotypic Screening Platform Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Drug Phenotypic Screening Platform Revenue Market Share by Type (2026-2031)
Table 27. Global Drug Phenotypic Screening Platform Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Drug Phenotypic Screening Platform Revenue Market Share by Application (2020-2025)
Table 29. Global Drug Phenotypic Screening Platform Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Drug Phenotypic Screening Platform Revenue Market Share by Application (2026-2031)
Table 31. North America Drug Phenotypic Screening Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Drug Phenotypic Screening Platform Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Drug Phenotypic Screening Platform Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Drug Phenotypic Screening Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Drug Phenotypic Screening Platform Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Drug Phenotypic Screening Platform Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Drug Phenotypic Screening Platform Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Drug Phenotypic Screening Platform Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Drug Phenotypic Screening Platform Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Drug Phenotypic Screening Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Drug Phenotypic Screening Platform Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Drug Phenotypic Screening Platform Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Drug Phenotypic Screening Platform Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Drug Phenotypic Screening Platform Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Drug Phenotypic Screening Platform Market Size by Country (2026-2031) & (US$ Million)
Table 46. Melior Discovery Company Details
Table 47. Melior Discovery Business Overview
Table 48. Melior Discovery Drug Phenotypic Screening Platform Product
Table 49. Melior Discovery Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)
Table 50. Melior Discovery Recent Development
Table 51. Creative Biolabs Company Details
Table 52. Creative Biolabs Business Overview
Table 53. Creative Biolabs Drug Phenotypic Screening Platform Product
Table 54. Creative Biolabs Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)
Table 55. Creative Biolabs Recent Development
Table 56. PerkinElmer Company Details
Table 57. PerkinElmer Business Overview
Table 58. PerkinElmer Drug Phenotypic Screening Platform Product
Table 59. PerkinElmer Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)
Table 60. PerkinElmer Recent Development
Table 61. TargetMol Company Details
Table 62. TargetMol Business Overview
Table 63. TargetMol Drug Phenotypic Screening Platform Product
Table 64. TargetMol Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)
Table 65. TargetMol Recent Development
Table 66. MIMETAS Company Details
Table 67. MIMETAS Business Overview
Table 68. MIMETAS Drug Phenotypic Screening Platform Product
Table 69. MIMETAS Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)
Table 70. MIMETAS Recent Development
Table 71. Evotec Company Details
Table 72. Evotec Business Overview
Table 73. Evotec Drug Phenotypic Screening Platform Product
Table 74. Evotec Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)
Table 75. Evotec Recent Development
Table 76. ThermoScientific Company Details
Table 77. ThermoScientific Business Overview
Table 78. ThermoScientific Drug Phenotypic Screening Platform Product
Table 79. ThermoScientific Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)
Table 80. ThermoScientific Recent Development
Table 81. Eurofins Discovery Company Details
Table 82. Eurofins Discovery Business Overview
Table 83. Eurofins Discovery Drug Phenotypic Screening Platform Product
Table 84. Eurofins Discovery Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)
Table 85. Eurofins Discovery Recent Development
Table 86. Horizon Discovery Company Details
Table 87. Horizon Discovery Business Overview
Table 88. Horizon Discovery Drug Phenotypic Screening Platform Product
Table 89. Horizon Discovery Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)
Table 90. Horizon Discovery Recent Development
Table 91. Crown Bioscience Company Details
Table 92. Crown Bioscience Business Overview
Table 93. Crown Bioscience Drug Phenotypic Screening Platform Product
Table 94. Crown Bioscience Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)
Table 95. Crown Bioscience Recent Development
Table 96. Pharmaron Company Details
Table 97. Pharmaron Business Overview
Table 98. Pharmaron Drug Phenotypic Screening Platform Product
Table 99. Pharmaron Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)
Table 100. Pharmaron Recent Development
Table 101. HD Biosciences Company Details
Table 102. HD Biosciences Business Overview
Table 103. HD Biosciences Drug Phenotypic Screening Platform Product
Table 104. HD Biosciences Revenue in Drug Phenotypic Screening Platform Business (2020-2025) & (US$ Million)
Table 105. HD Biosciences Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Drug Phenotypic Screening Platform Picture
Figure 2. Global Drug Phenotypic Screening Platform Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drug Phenotypic Screening Platform Market Share by Type: 2024 VS 2031
Figure 4. In Vivo Screening Features
Figure 5. In Vitro Screening Features
Figure 6. Global Drug Phenotypic Screening Platform Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Drug Phenotypic Screening Platform Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical Company Case Studies
Figure 9. Research Institute Case Studies
Figure 10. Others Case Studies
Figure 11. Drug Phenotypic Screening Platform Report Years Considered
Figure 12. Global Drug Phenotypic Screening Platform Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Drug Phenotypic Screening Platform Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Drug Phenotypic Screening Platform Market Share by Region: 2024 VS 2031
Figure 15. Global Drug Phenotypic Screening Platform Market Share by Players in 2024
Figure 16. Global Top Drug Phenotypic Screening Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Phenotypic Screening Platform as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Drug Phenotypic Screening Platform Revenue in 2024
Figure 18. North America Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Drug Phenotypic Screening Platform Market Share by Country (2020-2031)
Figure 20. United States Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Drug Phenotypic Screening Platform Market Share by Country (2020-2031)
Figure 24. Germany Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Drug Phenotypic Screening Platform Market Share by Region (2020-2031)
Figure 32. China Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Drug Phenotypic Screening Platform Market Share by Country (2020-2031)
Figure 40. Mexico Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Drug Phenotypic Screening Platform Market Share by Country (2020-2031)
Figure 44. Turkey Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Drug Phenotypic Screening Platform Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Melior Discovery Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)
Figure 48. Creative Biolabs Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)
Figure 49. PerkinElmer Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)
Figure 50. TargetMol Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)
Figure 51. MIMETAS Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)
Figure 52. Evotec Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)
Figure 53. ThermoScientific Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)
Figure 54. Eurofins Discovery Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)
Figure 55. Horizon Discovery Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)
Figure 56. Crown Bioscience Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)
Figure 57. Pharmaron Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)
Figure 58. HD Biosciences Revenue Growth Rate in Drug Phenotypic Screening Platform Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232